Artificial Intelligence
Outlook on the AI-Enabled Medical Imaging Solutions Global Market to 2030 – Featuring General Electric, Hyperfine and Hologic Among Others
Dublin, Jan. 22, 2021 (GLOBE NEWSWIRE) — The “Global AI-Enabled Medical Imaging Solutions Market: 15 Countries Analysis – Analysis and Forecast, 2020-2030” report has been added to ResearchAndMarkets.com’s offering.
The global AI-enabled medical imaging solutions market was valued at $636.1 million in 2019 and is anticipated to reach $10,145.1 million by 2030, growing at a CAGR of 26.69%, during the forecast period 2020 -2030.
The increasing complexities in clinical decision making, rising radiologist workload, and huge R&D investments are the major factors fueling market growth. In addition to these factors, there are significant challenges and restraints, which are restricting market growth. These challenges include the physicians’ reluctance toward the adoption of advanced technologies such as AI and the privacy and security concerns related to healthcare data. Hence, it is anticipated that these trends will have a significant impact on AI-enabled medical imaging solutions market in the next five years, and the market will grow multifold.
Global AI-enabled imaging modalities market is currently witnessing a significant change in the market landscape. There is rising investment in development of healthcare infrastructure, increasing evidences for efficient and promising results in treatment and diagnosis assistance. Thus, this is leading to potential growth opportunities for the AI-enabled imaging modalities market. Moreover, there is an extensive entry of emerging players developing AI-powered imaging systems, and software companies into the healthcare space. All these predominant factors have led to a significant rise in sales of AI-based imaging modality systems across the globe.
Market Report Coverage – AI-Enabled Medical Imaging Solutions
Market Segmentation
- Therapeutic Application – Cardiology, Oncology (Breast, Lung, Other Cancer Types), Neurology, Respiratory, Orthopedic, and Others
- Modality – CT, MRI, X-Ray, Ultrasound, PET, Other Modalities
- Workflow – Image Acquisition, Image Analysis, Detection, Diagnosis, and Treatment Decision Support, Predictive Analysis & Risk Assessment, Triage, Reporting and Communication, and Equipment Maintenance
Regional Segmentation
- North America – U.S. and Canada
- Europe – Germany, U.K, Italy, Spain, France, Switzerland, Sweden, Netherlands, and Rest of -Europe
- Asia-Pacific – Japan, China, South Korea, Australia and New Zealand, Singapore, and Rest of -Asia -Pacific
- Rest-of-the-World
Growth Drivers
- Increasing Complexities of Clinical Decision -Making
- Expanding Range of Applications
- Shortage of Healthcare Workforce
- Huge R&D investment
Market Challenges
- Privacy and Security Concerns Related to Healthcare Data
- Regulatory Challenges
- Barriers to Physician’s Adoption of AI
- Lag in Regulatory Approvals
- Legal Implications of AI Systems
- Rise in Medical Imaging Expenses
- Data Security and Privacy Issues
- Lack of Trained Staff
Market Opportunities
- Rapidly Evolving Deep Learning Techniques
- Increasing Number of Cross-Industry Partnerships
Key Companies Profiled
Siemens Healthineers AG., General Electric Company, Agfa – Gevart Group, Hologic, Inc., Fujifilm Holdings Corporation, General Electric Company, iCAD, Inc., Koninklijke Philips N.V., Nuance Communications, Inc., Synopsys Inc., NVIDIA Corporation, Nanox, Butterfly Network, Inc., Hyperfine. Aidoc, Arterys Inc, Beijing Infervision Technology Co., Ltd., Blackford Analysis Limited, Envoy AI, MIRADA MEDICAL LIMITED, VUNO Inc., and Zebra Medical Vision, Inc.
Key Questions Answered in this Report:
- What are the various AI-enabled medical imaging solutions and systems available in the market?
- What is the current market size and future potential of these products?
- What are the major market drivers, challenges, and opportunities in the global AI-enabled medical imaging solutions market?
- What are the guidelines implemented by different government bodies to regulate the approval of AI-enabled medical imaging solutions?
- What are the key technological developments on which the current industry leaders are spending a major share of their research and development (R&D) investments?
- Who are the leading players holding dominating shares in the global AI-enabled medical imaging solutions market, currently?
- What are the key strategies incorporated by the players of global AI-enabled medical imaging solutions market, to sustain the competition and retain their supremacy?
- What is the current revenue contribution of different therapeutic applications, workflow, and modality, and how would it evolve in the forecast period?
- What is the current demand contribution of different product types and how would it evolve in the forecast period?
- What is the current demand contribution of different deployment models and how would it evolve in the forecast period?
- Which countries contribute to the major share of current demand and which countries hold significant scope for expansion for business activities, by players of the global AI-enabled medical imaging solutions market?
Key Topics Covered:
1 Product Definition
2 Research Scope
3 Research Methodology
4 Industry Insights
4.1 Industry Ecosystem
4.2 Legal Requirements and Regulations
4.2.1 Regulatory Framework for Artificial Intelligence-Based FDA-Approved Medical Devices and Algorithms
4.2.1.1 Restraints in Current Regulatory Process for AI/ML-Based Medical Device/Algorithm
4.2.2 Regulatory Framework in the U.S.
4.2.3 Regulatory Framework in Europe
4.2.3.1 Changes in Rule
4.2.3.2 New Rules in the Annexure VIII
4.2.3.3 Major Changes in the EU due to the Implementation of MDR:
4.2.3.3.1 Expanded Device Definitions Requiring Re-Examination of the Current Classification of All Devices
4.2.3.3.2 Quality Management System
4.2.3.3.3 Technical File
4.2.3.3.4 Need to Comply with New Identification and Traceability (UDI) Requirements
4.2.3.3.5 More Emphasis on Post-Market Surveillance
4.2.3.3.6 Need for Strengthening the Role of Internal Audits and Mandatory Audits
4.2.3.3.7 Dedicated Personnel for MDR compliance
4.2.4 Regulatory Framework in Japan
4.2.5 Regulatory Framework in China
4.2.6 Regulatory Framework in Other Countries
4.2.6.1 Regulatory Framework in India
4.2.6.2 Regulatory Framework in Latin America
4.2.6.3 Regulatory Framework in the Middle East and Africa (MEA)
4.2.7 Consortiums, Associations, and Regulatory Bodies
4.3 Impact of COVID-19
4.3.1 Impact on Clinical Settings and Clinical Decision-Making
4.3.2 Impact on AI-Based Medical Imaging Solution Manufacturers
4.3.3 Conclusion
5 Real World Evidence
5.1 Overview
5.2 Aidoc
5.2.1 Role of Aidoc in the Global AI-Enabled Medical Imaging Solutions Market
5.3 Arterys Inc.
5.3.1 Role of Arterys Inc. in the Global AI-Enabled Medical Imaging Solutions Market
5.4 Bay Labs, Inc.
5.4.1 Role of Bay Labs, Inc. in the Global AI-Enabled Medical Imaging Solutions Market
5.5 Heart Flow, Inc.
5.5.1 Role of Heart Flow, Inc. in the Global AI-Enabled Medical Imaging Solutions Market
5.6 MIRADA MEDICAL LIMITED
5.6.1 Role of Mirada Medical Limited in the Global AI-Enabled Medical Imaging Solutions Market
5.7 RADLogics Inc.
5.7.1 Role of RADLogics Inc. in the Global AI-Enabled Medical Imaging Solutions Market
5.8 VIDA Diagnostics, Inc.
5.8.1 Role of VIDA Diagnostics, Inc. in the Global AI-Enabled Medical Imaging Solutions Market
5.9 VUNO Inc.
5.9.1 Role of VUNO lnc. in the Global AI-Enabled Medical Imaging Solutions Market
5.1 Zebra Medical Vision, Inc.
5.10.1 Role of Zebra Medical Vision, Inc. in the Global AI-Enabled Medical Imaging Solutions Market
6 Global AI-Enabled Medical Imaging Solutions Market Scenario
6.1 Assumptions and Limitations
6.2 Global Market Scenario
6.3 Potential Market Opportunities
6.3.1 Rapidly Evolving Deep Learning Techniques
6.3.2 Increasing Number of Cross-Industry Partnerships
6.4 Market Dynamics
6.4.1 Impact Analysis
6.4.2 Market Drivers
6.4.2.1 Increasing Complexities of Clinical Decision-Making
6.4.2.2 Expanding Range of Applications
6.4.2.3 Shortage of Healthcare Workforce
6.4.2.4 Huge R&D Investments
6.4.3 Market Restraints
6.4.3.1 Privacy and Security Concerns Related to Healthcare Data
6.4.3.2 Regulatory Challenges
6.4.3.3 Barriers to Physician’s Adoption of AI
6.4.3.4 Lag in Regulatory Approvals
6.4.3.5 Legal Implications of AI Systems
6.4.3.6 Rise in Medical Imaging Expenses
6.4.3.7 Data Security and Privacy Issues
6.4.3.8 Lack of Trained Staff
7 Competitive Landscape
7.1 Key Strategies and Developments
7.1.1 Joint Ventures, Collaborations, and Partnerships
7.1.2 Funding and Investments
7.1.3 Regulatory and Legal Activities.
7.1.3.1 U.S. FDA Approvals
7.1.3.2 CE Mark Approvals
7.1.3.3 PMDA Approvals
7.1.3.4 Others
7.1.4 Product Launches and Enhancements
7.1.5 Mergers and Acquisitions
7.2 Growth Share Analysis
7.2.1 Growth Share Matrix (by Product)
7.2.2 Growth Share Matrix (by Workflow)
7.2.3 Growth Share Matrix (by Modality)
8 Global AI-Enabled Medical Imaging Solutions Market (by Modality)
8.1 Overview
8.2 Computed Tomography (CT)
8.3 Magnetic Resonance (MR)
8.4 Ultrasound
8.5 X-Ray
8.6 Mammography
8.7 Multimodality Imaging Systems
8.8 Other Modalities
9 Global AI-Enabled Medical Imaging Solutions Market (by Product)
9.1 Overview
9.2 Software
9.2.1 Perpetual Software License
9.2.2 Subscription Software License
9.2.3 Fee-Per Case Software License
9.3 Hardware
10 Global AI-Enabled Medical Imaging Solutions Market (by Deployment Model)
10.1 Overview
10.2 Cloud- and Web-Based Solutions
10.3 On-Premises Solutions
11 Global AI-Enabled Medical Imaging Solutions Market (by Workflow), 2019-2030
11.1 Overview
11.2 Image Acquisition
11.3 Image Analysis
11.4 Detection
11.5 Diagnosis and Treatment Decision Support
11.6 Predictive Analysis and Risk Assessment
11.7 Triage
11.8 Reporting and Communication
12 Global AI-Enabled Medical Imaging Solutions Market (by Therapeutic Application)
12.1 Overview
12.2 Specialty Imaging
12.2.1 Cardiology
12.2.2 Oncology
12.2.2.1 Lung Cancer
12.2.2.2 Breast Cancer
12.2.2.3 Other Cancer Types
12.2.3 Neurology
12.2.4 Respiratory
12.2.5 Orthopedics
12.2.6 Others
12.3 General Imaging
13 Global AI-Enabled Medical Imaging Solutions Market (by Region)
13.1 Overview
13.2 North America
13.3 Europe
13.4 Asia-Pacific
13.5 Rest-of-the-World (RoW)
14 Company Profiles
14.1 Overview
14.2 Agfa-Gevaert Group
14.3 Butterfly Network, Inc.
14.4 Fujifilm Holdings Corporation
14.5 General Electric Company
14.6 Hyperfine
14.7 Hologic, Inc.
14.8 Koninklije Philips N.V.
14.9 Nanox
14.1 Siemens Healthineers AG
14.11 Aidoc
14.12 Arterys Inc.
14.13 Beijing Infervision Technology Co., Ltd.
14.14 Blackford Analysis Limited
14.15 Eureka Clinical AI, formerly known as EnvoyAI
14.16 iCAD, Inc.
14.17 MIRADA MEDICAL LIMITED
14.18 Nuance Communications, Inc.
14.19 NVIDIA Corporation
14.2 Synopsys, Inc.
14.21 VUNO lnc.
14.22 Zebra Medical Vision, Inc.
For more information about this report visit https://www.researchandmarkets.com/r/bclmf4
CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager [email protected] For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Artificial Intelligence
XtalPi Unveils XtalGazer: A Comprehensive AI-Driven Polymorph Selection Platform
CAMBRIDGE, Mass., March 28, 2024 /PRNewswire/ — XtalPi Inc., a leading global technology company in integrating artificial intelligence (AI) and robotics to advance the discovery of groundbreaking medicine and innovative materials, announced today the launch of its proprietary comprehensive solid form discovery and selection platform, XtalGazer. This advanced platform aims to significantly improve the polymorph selection process for the pharmaceutical industry by integrating AI- and automation-powered experimental and computational approaches.
XtalGazer provides a total solution for delivering high-quality polymorph screening and selection methods to expedite drug development and mitigate risks. It represents a paradigm shift in solid-state research, moving from the traditional trial-and-error approach to a data-driven, design-led methodology. The platform provides an expansive suite of foundational tools to accelerate polymorph discovery, characterization, and selection process, empowering pharmaceutical companies to conduct thorough research with less active pharmaceutical ingredient (API) in shorter development cycles.
A key component of XtalGazer is XtalCSP, a crystal structure prediction platform to perform global searches of crystal structures for target molecules and the other optional components in the corresponding searching space, offering a deep insight into possible stable forms. Furthermore, crystallization strategy recommendations will provide AI-backed experimental design to help avoid human bias. XtalGazer also utilizes MicroED to rapidly elucidate crystal structures from powder samples, reducing the need for growing single crystals.
XtalPi’s launch of XtalGazer marks another significant step in the company’s ongoing exploration of solid-state research. From crystal structure prediction platforms being one of the first products to launch at XtalPi, to today’s comprehensive polymorph selection platform, XtalPi will keep fulfilling its promise to solving challenging problems in this space. XtalPi will continue to deliver faster, more accurate, and more comprehensive approaches to building an ecosystem for the R&D process in solid-state, pre-formulation and crystallization.
For more information about XtalPi, please visit www.xtalpi.com.
About XtalPi:
XtalPi is an innovative technology company powered by artificial intelligence (AI) and robotics. Founded in 2015 on the MIT campus, XtalPi is dedicated to driving intelligent and digital transformation in the life science and new materials industries. With tightly interwoven quantum physics, AI, cloud computing, and large-scale clusters of robotic workstations, XtalPi offers a range of technology solutions, services, and products to accelerate and empower innovation for biopharmaceutical and new materials companies worldwide.
Media Contact: Vivienne [email protected]
Logo – https://mma.prnewswire.com/media/632519/XtalPi_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/xtalpi-unveils-xtalgazer-a-comprehensive-ai-driven-polymorph-selection-platform-302102794.html
Artificial Intelligence
ICIS and Base Oil News Announce Partnership to Enhance Market Insights
LONDON, March 28, 2024 /PRNewswire/ — ICIS, a global source of commodity intelligence, is pleased to announce a strategic partnership with Base Oil News, a premier news outlet founded by industry expert Iain Pocock that provides in-depth coverage of the base oils and lubricants market. This collaboration marks a significant milestone in the dissemination and exchange of critical market data and insights.
With more than two decades of journalism experience at Bloomberg, Reuters, and Argus Media, Iain Pocock brings unparalleled expertise to this partnership. His deep understanding of illiquid energy markets makes him a credible and influential figure in the industry. Since November 2023, Iain has been working closely with ICIS to share and exchange valuable data and insights, enhancing the services both platforms offer to the base oils and lubricants market.
Through the collaboration, Iain integrates ICIS’ extensive content and data resources in Base Oil News market coverage. In return, he contributes market insights to ICIS News, including expert and exclusive analysis of supply and demand dynamics, price margins, and other critical market drivers. This exchange ensures that subscribers of both ICIS and Base Oil News have access to the most comprehensive, timely, and accurate market information, empowering them to make informed decisions.
“It’s a very exciting partnership – where we leverage each other’s strengths and provide actionable insights to our customers,” said Iain Pocock, Founder of Base Oil News. “The market is the winner.”
“As ICIS is already the world’s most trusted pricing benchmark for base oils, this collaboration with Iain Pocock and Base Oil News provides an even stronger and deeper service to our customers,” said Stephen Burns, Editorial Director at ICIS. “Iain’s expertise and extensive industry connections are invaluable, and we have established a fruitful partnership that benefits the market at large.”
For the latest insights from Iain Pocock on ICIS News, visit ICIS News.
About ICIS
ICIS – Independent Commodity Intelligence Services – helps businesses through seamlessly delivering data and analytics, across the chemical, fertilizer and energy markets. A trusted source and benchmark for price information and insight across key commodities markets worldwide. Our independent, transparent market intelligence informs thousands of quality decisions every day, taking the pressure out of negotiations and giving customers space for more innovative thinking, through published datasets including price assessments, price forecasts, supply and demand fundamentals and more.
Over 150 years of shaping the world by connecting markets to optimise the world’s valuable resources. With a global team of more than 600 experts, ICIS has employees based in London, New York, Houston, Karlsruhe, Milan, Mumbai, Singapore, Guangzhou, Beijing, Shanghai, Dubai, Sao Paulo, Seoul, Tokyo and Perth.
ICIS is part of RELX, a FTSE15 company with a market cap of £64bn and an employee base of over 30,000 experts across 40 countries.
About RELX
RELX is a global provider of information and analytics for professional and business customers across industries. The Group serves customers in more than 180 countries and has offices in about 40 countries. It employs approximately 30,000 people of whom almost half are in North America. RELX PLC is a London listed holding company which owns 52.9% of RELX Group. RELX NV is an Amsterdam listed holding company which owns 47.1% of RELX Group. The shares are traded on the London, Amsterdam and New York Stock Exchanges using the following ticker symbols: London: REL; Amsterdam: REN; New York: RELX and RENX. Total market capitalisation is approximately £64bn | €75bn | $81bn.
Logo: https://mma.prnewswire.com/media/619935/4277787/ICIS_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/icis-and-base-oil-news-announce-partnership-to-enhance-market-insights-302102782.html
Artificial Intelligence
Trianz Welcomes Israel Abraham as Vice President of Services for Extrica.ai – The Data to AI Platform
SANTA CLARA, Calif., March 28, 2024 /PRNewswire/ — Digital transformation technology & services company Trianz is pleased to announce the appointment of Israel Abraham as Vice President of Extrica Platform Services.
Trianz has embarked on a transformative journey, redefining its value proposition with an ‘IP Led’ model, with a commitment to deliver the fastest time to value, lowest human dependence, and highest ROI. Central to this approach are our hyper-automated platforms, Concierto.Cloud, Extrica.AI, and Pulse, driving industry-leading transformations in cloud, data and analytics, AI, and the digital workplace.
Israel Abraham is a very well-known pioneer and industry leader in AI, data management, and analytics systems, with over three decades of experience. He joins as the services leader for Extrica- the Trianz Data to AI platform, which productizes data, provides data a face and purpose, and accelerates time to insights and AI by 50% or more. In the role of Extrica Services leader, Israel will lead the shaping, visioning, and delivery of Extrica.ai based enterprise wide datamesh, BI, and AI solutions for customers worldwide.
“We are thrilled to welcome Israel Abraham to the Trianz family,” said Sri Manchala, CEO of Trianz and author of Crossing the Digital Faultline. “He is a leader in modernization as well as conceptualization of data platforms anew. Israel’s prior background in the industry with financial services and insurance giants underscores our commitment to securing top-tier talent that brings real-world experiences and needs to our technology platforms. As we continue to broaden our footprint in the digital transformation space, Israel’s visionary leadership and practical experience will serve as the cornerstone in accelerating insights and AI to deliver transformative value to our clients.”
Having played pivotal roles in highly reputed and large organizations such as Liberty Mutual Insurance, MassMutual, Safeco, and CNA Insurance, Israel has garnered recognition as a seasoned leader in big data and AI cloud implementations. His accolades include the prestigious 2014 Ventana Research IT Innovation Award, the 2009 Informatica MDM Innovation Award, and three filed Data Engineering patents in the last four years.
“Trianz has been at the forefront of digital innovation, and Extrica.ai is a paradigm shifting data to AI platform that completely changes how analytics and AI are delivered- much faster, taking business ahead of change. I am excited to scale the adoption of the Extrica platform, which has attracted attention from giants across the industry and hyperscalers,” said Israel Abraham. “I look forward to engaging with customers, bringing my own experiences, and collaborating with the talented team at Trianz to further enhance the capabilities of the Extrica Platform Services to transform data & AI strategies, execution, and outcomes for customers.”
About Trianz
Trianz is a leading-edge technology platforms and services company that accelerates digital transformations at Fortune 100 and emerging companies worldwide in data & analytics, digital experiences, cloud infrastructure, and security. Our ‘IP Led Transformations’ approach, informed by insights from a recent global study spanning 20+ industries and 5000+ companies, addresses challenges posed by the rapid pace of AI-driven transformation, digital talent scarcity, and economic uncertainty. Our IP and platforms, including Concierto, Extrica, and Pulse, revolutionize cloud adoption, data analytics, and AI insights, empowering organizations to navigate the complexities of digital transformation seamlessly.
Founded in California and with an organization of over 2,000 associates across the United States and India, Trianz is a Premier Partner of AWS, consistently rated #1 by clients for value delivery over the past five years. Trianz has been ranked as one of the best Consulting Firms by Forbes and has been certified as a Great Place to Work for three years in a row. To learn more about Trianz, email [email protected] or visit www.trianz.com.
Watch Trianz CEO Sri Manchala’s insightful interview with Bloomberg on Partner | Crossing The Digital Faultline & Leading Towards Transformative Success – YouTube and delve deeper into his book Crossing the Digital Faultline at Crossing the Digital Faultline | Trianz.
Trianz Media [email protected] +1-408-387-5800
Logo: https://mma.prnewswire.com/media/626944/1199800/Trianz_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/trianz-welcomes-israel-abraham-as-vice-president-of-services-for-extricaai–the-data-to-ai-platform-302102589.html
-
Artificial Intelligence6 days ago
Document Collaboration Hub (DCH) by Netcare International Now Available on Microsoft AppSource
-
Artificial Intelligence6 days ago
Smartkem Commences Project with RiTdisplay To Develop World’s First Commercially Ready Active-Matrix OLED Display Using OTFT Technology
-
Artificial Intelligence6 days ago
Hexaware Dominates Whitelane Research 2024 BeLux IT Sourcing Study: A Triumph in Continued CSAT Excellence
-
Artificial Intelligence6 days ago
Wine of Moldova offers a glimpse of the future with its game-changing AI tool
-
Artificial Intelligence6 days ago
World System Integrator Conference (WSIC) 2024 A Showcase of New Initiatives
-
Artificial Intelligence6 days ago
Disaster Preparedness Systems Market Projected to Reach $300.20 billion by 2030 – Exclusive Report by 360iResearch
-
Artificial Intelligence6 days ago
Decision Intelligence Market worth $50.1 billion by 2030 – Exclusive Report by MarketsandMarkets™
-
Artificial Intelligence6 days ago
YASH Technologies Partners with Baheya Foundation to Transform Cancer Care in Egypt